[18F] - 氟脱氧葡萄糖正电子发射断层扫描在妇科和乳腺癌的初始检测、分期、复发查找及再分期中的作用

[Role of [18F]-fluorodeoxyglucose positron emission tomography for the initial detection, staging, search for recurrences and restaging of gynaecological and breast cancers].

作者信息

Grahek D, Barranger E, Daraï E, Uzan S, Talbot J-N

机构信息

Centre TEP et service de médecine nucléaire, hôpital Tenon, Paris, France.

出版信息

Gynecol Obstet Fertil. 2005 Jun;33(6):371-81. doi: 10.1016/j.gyobfe.2005.01.005.

DOI:10.1016/j.gyobfe.2005.01.005

PMID:15927502

Abstract

Positron emission tomography (PET) using fluorodeoxyglucose (FDG) is a new metabolic imaging modality that is becoming accessible in France. Many centers have been or will be equipped soon. The indications of PET-FDG have been established in various settings in some oncology pathologies such as lymphoma or lung cancer, but not in gynaecological and breast cancers. Therefore, we aimed to precise the interest of PET-FDG to detect, stage and restage the cancers of breast, ovary, cervix and uterus by reviewing the recent publications.

摘要

使用氟脱氧葡萄糖（FDG）的正电子发射断层扫描（PET）是一种新的代谢成像方式，在法国正逐渐普及。许多中心已经或即将很快配备该设备。PET-FDG的适应症已在某些肿瘤病理学的各种情况下得到确立，如淋巴瘤或肺癌，但在妇科和乳腺癌中尚未确立。因此，我们旨在通过回顾近期的出版物来明确PET-FDG在检测、分期和再分期乳腺癌、卵巢癌、宫颈癌和子宫癌方面的价值。